APLS icon

Apellis Pharmaceuticals
APLS

Overview Fund Activity

249 hedge funds and large institutions have $6.65B invested in Apellis Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 67 funds opening new positions, 93 increasing their positions, 65 reducing their positions, and 26 closing their positions.

Holders
249
Holders Change
+40
Holders Change %
+19.14%
% of All Funds
4.31%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.17%
New
67
Increased
93
Reduced
65
Closed
26
Calls
$92M
Puts
$111M
Net Calls
-$19.4M
Net Calls Change
-$52.7M

Top Buyers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$377M
2
AG
2
Artal Group
Luxembourg
$68.3M
3
Lord, Abbett & Co
3
Lord, Abbett & Co
New Jersey
$64.6M
4
Viking Global Investors
4
Viking Global Investors
Connecticut
$63.7M
5
APM
5
Avidity Partners Management
Texas
$57.6M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$229M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$680M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$23M
4
State Street
4
State Street
Massachusetts
$202M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
ACA
1
Avoro Capital Advisors
New York
$692M 10,125,000 +320,000 +3%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$680M 9,957,416 -1,585,327 -14%
Vanguard Group
3
Vanguard Group
Pennsylvania
$617M 9,031,079 +304,334 +3%
BlackRock
4
BlackRock
New York
$484M 7,086,330 +287,786 +4%
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$377M 5,516,123 +5,516,123 New
EC
6
EcoR1 Capital
California
$354M 5,183,431 – –
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$229M 3,350,963 -5,328,850 -61%
State Street
8
State Street
Massachusetts
$202M 2,957,273 -539,652 -15%
Jennison Associates
9
Jennison Associates
New York
$173M 2,534,712 +236,365 +10%
OCA
10
Octagon Capital Advisors
New York
$171M 2,503,059 -80,000 -3%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$116M 1,691,202 +81,040 +5%
CAM
12
Cormorant Asset Management
Massachusetts
$101M 1,478,000 +528,000 +56%
Fidelity Investments
13
Fidelity Investments
Massachusetts
$99.7M 1,460,164 +71,737 +5%
Macquarie Group
14
Macquarie Group
Australia
$97.2M 1,421,535 +38,028 +3%
BC
15
Boxer Capital
California
$89M 1,303,700 – –
LGM
16
Logos Global Management
California
$88.8M 1,300,000 -200,000 -13%
Assenagon Asset Management
17
Assenagon Asset Management
Luxembourg
$83.7M 1,225,336 +341,898 +39%
BG
18
Bellevue Group
Switzerland
$68.8M 1,007,444 -198,978 -16%
AG
19
Artal Group
Luxembourg
$68.3M 1,000,000 +1,000,000 New
PAMS
20
Pictet Asset Management (Switzerland)
Switzerland
$67.5M 987,567 +9,909 +1%
Norges Bank
21
Norges Bank
Norway
$66.5M 972,974 +27,094 +3%
Goldman Sachs
22
Goldman Sachs
New York
$65.4M 957,678 +147,279 +18%
Charles Schwab
23
Charles Schwab
California
$64.8M 948,759 +270,358 +40%
Lord, Abbett & Co
24
Lord, Abbett & Co
New Jersey
$64.6M 946,526 +946,526 New
JPMorgan Chase & Co
25
JPMorgan Chase & Co
New York
$64.2M 940,047 -133,918 -12%
1
2 3 4 5